290 related articles for article (PubMed ID: 35958902)
1. Hypogonadism and urologic surgeries: a narrative review.
Fendereski K; Ghaed MA; Calvert JK; Hotaling JM
Transl Androl Urol; 2022 Jul; 11(7):1045-1062. PubMed ID: 35958902
[TBL] [Abstract][Full Text] [Related]
2. Androgens and Urethral Health: How Hypogonadism Affects Postoperative Outcomes of Patients Undergoing Artificial Urinary Sphincter or Inflatable Penile Prosthesis Placement.
Prebay ZJ; Fu DH; Chung PH
Urology; 2024 Feb; 184():266-271. PubMed ID: 37972898
[TBL] [Abstract][Full Text] [Related]
3. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
[TBL] [Abstract][Full Text] [Related]
4. The role of testosterone in men's health: is it time for a new approach?
Diokno AC
Int Urol Nephrol; 2022 Nov; 54(11):2767-2774. PubMed ID: 35909146
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of prostate cancer in patients receiving testosterone supplementation for hypogonadism.
Gray H; Seltzer J; Talbert RL
Am J Health Syst Pharm; 2015 Apr; 72(7):536-41. PubMed ID: 25788507
[TBL] [Abstract][Full Text] [Related]
7. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
[TBL] [Abstract][Full Text] [Related]
8. Untreated hypogonadism and testosterone replacement therapy in hypogonadal men are associated with a decreased risk of subsequent prostate cancer: a population-based study.
Asanad K; Horns JJ; Driggs N; Samplaski MK; Hotaling JM
Int J Impot Res; 2024 Jan; ():. PubMed ID: 38177194
[TBL] [Abstract][Full Text] [Related]
9. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
10. Testosterone and the Prostate.
Tan RB; Silberstein JL; Hellstrom WJ
Sex Med Rev; 2014 Oct; 2(3-4):112-120. PubMed ID: 27784562
[TBL] [Abstract][Full Text] [Related]
11. Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer.
Lenfant L; Leon P; Cancel-Tassin G; Audouin M; Staerman F; Rouprêt M; Cussenot O
Urol Oncol; 2020 Aug; 38(8):661-670. PubMed ID: 32409202
[TBL] [Abstract][Full Text] [Related]
12. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
13. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
14. Exogenous Testosterone Replacement Therapy Is Associated with Increased Risk for Vascular Graft Infections Among Hypogonadal Men.
Longwolf KJ; Johnson CE; Horns JJ; Hotaling JM; Brooke BS
Ann Vasc Surg; 2023 Nov; 97():113-120. PubMed ID: 37453467
[TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement in prostate cancer survivors with hypogonadal symptoms.
Leibowitz RL; Dorff TB; Tucker S; Symanowski J; Vogelzang NJ
BJU Int; 2010 May; 105(10):1397-401. PubMed ID: 19912179
[TBL] [Abstract][Full Text] [Related]
16. [Age-related androgen deficiency and benign prostatic hyperplasia: how to improve the rehabilitation of patients after transurethral surgery?].
Martov AG; Ergakov DV
Urologiia; 2016 Dec; (6):110-117. PubMed ID: 28248054
[TBL] [Abstract][Full Text] [Related]
17. Testosterone and the prostate: implications for the treatment of hypogonadal men.
Holyoak JD; Crawford ED; Meacham RB
Curr Urol Rep; 2008 Nov; 9(6):500-5. PubMed ID: 18947516
[TBL] [Abstract][Full Text] [Related]
18. Testosterone replacement therapy following radical prostatectomy.
Khera M; Grober ED; Najari B; Colen JS; Mohamed O; Lamb DJ; Lipshultz LI
J Sex Med; 2009 Apr; 6(4):1165-1170. PubMed ID: 19207277
[TBL] [Abstract][Full Text] [Related]
19. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
[TBL] [Abstract][Full Text] [Related]
20. Prostate Risk and Monitoring During Testosterone Replacement Therapy.
Bhasin S; Thompson IM
J Clin Endocrinol Metab; 2024 May; ():. PubMed ID: 38753865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
